ESSA Pharma (NASDAQ:EPIX) Stock Price Passes Below 50 Day Moving Average of $2.39

Share on StockTwits

ESSA Pharma Inc (NASDAQ:EPIX) (TSE:EPI) shares passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $2.39 and traded as low as $2.28. ESSA Pharma shares last traded at $2.38, with a volume of 908 shares traded.

Several equities research analysts recently weighed in on the stock. Zacks Investment Research cut shares of ESSA Pharma from a “hold” rating to a “sell” rating in a research report on Thursday, May 16th. HC Wainwright restated a “buy” rating on shares of ESSA Pharma in a research report on Friday, May 17th.

The stock has a market capitalization of $14.39 million, a price-to-earnings ratio of -0.90 and a beta of 1.99. The company has a current ratio of 2.44, a quick ratio of 2.44 and a debt-to-equity ratio of 0.60.

TRADEMARK VIOLATION WARNING: This story was published by Ticker Report and is owned by of Ticker Report. If you are reading this story on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The correct version of this story can be accessed at https://www.tickerreport.com/banking-finance/4380112/essa-pharma-nasdaqepix-stock-price-passes-below-50-day-moving-average-of-2-39.html.

About ESSA Pharma (NASDAQ:EPIX)

ESSA Pharma Inc, a pharmaceutical company, focuses on the development of small molecule drugs for the treatment of prostate cancer. The company was founded in 2009 and is headquartered in Vancouver, Canada.

See Also: What are the benefits of a portfolio tracker?

Receive News & Ratings for ESSA Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ESSA Pharma and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

MKM Partners Lowers ADTRAN  Price Target to $17.00
MKM Partners Lowers ADTRAN Price Target to $17.00
Apple  PT Raised to $180.00 at Nomura
Apple PT Raised to $180.00 at Nomura
Advaxis  Lowered to “Hold” at ValuEngine
Advaxis Lowered to “Hold” at ValuEngine
Zacks Investment Research Upgrades Atlas Air Worldwide  to “Hold”
Zacks Investment Research Upgrades Atlas Air Worldwide to “Hold”
Apple  Raised to “Outperform” at Raymond James
Apple Raised to “Outperform” at Raymond James
Zacks Investment Research Lowers Agilysys  to Hold
Zacks Investment Research Lowers Agilysys to Hold


© 2006-2019 Ticker Report